Matches in SemOpenAlex for { <https://semopenalex.org/work/W2132919130> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2132919130 endingPage "1234" @default.
- W2132919130 startingPage "1221" @default.
- W2132919130 abstract "Angiogenesis is defined as the formation of new capillaries from prexisting blood vessels and plays an important role in the progression of solid tumors and hematologic malignancies. Markers of angiogenesis correlate with clinical characteristics in leukemia and non-Hodgkin´s-lymphoma, serving as predictors of poor prognosis. Antiangiogenic effects of chemotherapeutics as well as of novel drugs such as farnesyltransferase inhibitors and tyrosine kinase inhibitors such as Gleevec(r) might contribute to their therapeutic potential. Thalidomide which has antiangiogenic effects and direct cytotoxic effects was found to be effective in multiple myeloma and is considered as an established treatment modality for patients with refractory or relapsed multiple myeloma. Thalidomide has a significant therapeutic effect in myelodysplastic syndrome (MDS) by improving cytopenia and achieving independence of transfusion therapy in a subset of patients. Preliminary data indicate activity of specific VEGF receptor tyrosine kinase (RTK) inhibitors in multiple myeloma (MM) and acute myeloid leukemia (AML). The positive correlation between increased levels of angiogenic cytokines and clinical response to VEGF-RTK inhibitors and thalidomide indicates the relevance of detecting angiogenesis markers to identify best candidate patients for specific approaches. Including antiangiogenic drugs into treatment protocols for hematologic malignancies is an important task for future clinical studies. Keywords: angiogenesis, vasculogenesis, leukemia, lymphoma, multiple myeloma" @default.
- W2132919130 created "2016-06-24" @default.
- W2132919130 creator A5046718005 @default.
- W2132919130 creator A5047272364 @default.
- W2132919130 creator A5068472643 @default.
- W2132919130 creator A5084285813 @default.
- W2132919130 date "2004-04-01" @default.
- W2132919130 modified "2023-10-04" @default.
- W2132919130 title "Antiangiogenic Therapy in Hematologic Malignancies" @default.
- W2132919130 doi "https://doi.org/10.2174/1381612043452587" @default.
- W2132919130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15078137" @default.
- W2132919130 hasPublicationYear "2004" @default.
- W2132919130 type Work @default.
- W2132919130 sameAs 2132919130 @default.
- W2132919130 citedByCount "26" @default.
- W2132919130 countsByYear W21329191302012 @default.
- W2132919130 countsByYear W21329191302014 @default.
- W2132919130 countsByYear W21329191302015 @default.
- W2132919130 countsByYear W21329191302016 @default.
- W2132919130 countsByYear W21329191302017 @default.
- W2132919130 countsByYear W21329191302019 @default.
- W2132919130 countsByYear W21329191302021 @default.
- W2132919130 crossrefType "journal-article" @default.
- W2132919130 hasAuthorship W2132919130A5046718005 @default.
- W2132919130 hasAuthorship W2132919130A5047272364 @default.
- W2132919130 hasAuthorship W2132919130A5068472643 @default.
- W2132919130 hasAuthorship W2132919130A5084285813 @default.
- W2132919130 hasConcept C126322002 @default.
- W2132919130 hasConcept C143998085 @default.
- W2132919130 hasConcept C203014093 @default.
- W2132919130 hasConcept C2776063141 @default.
- W2132919130 hasConcept C2776364478 @default.
- W2132919130 hasConcept C2778461978 @default.
- W2132919130 hasConcept C2778729363 @default.
- W2132919130 hasConcept C2779338263 @default.
- W2132919130 hasConcept C2779609412 @default.
- W2132919130 hasConcept C2780007613 @default.
- W2132919130 hasConcept C2780366003 @default.
- W2132919130 hasConcept C2780394083 @default.
- W2132919130 hasConcept C2780817109 @default.
- W2132919130 hasConcept C502942594 @default.
- W2132919130 hasConcept C71924100 @default.
- W2132919130 hasConceptScore W2132919130C126322002 @default.
- W2132919130 hasConceptScore W2132919130C143998085 @default.
- W2132919130 hasConceptScore W2132919130C203014093 @default.
- W2132919130 hasConceptScore W2132919130C2776063141 @default.
- W2132919130 hasConceptScore W2132919130C2776364478 @default.
- W2132919130 hasConceptScore W2132919130C2778461978 @default.
- W2132919130 hasConceptScore W2132919130C2778729363 @default.
- W2132919130 hasConceptScore W2132919130C2779338263 @default.
- W2132919130 hasConceptScore W2132919130C2779609412 @default.
- W2132919130 hasConceptScore W2132919130C2780007613 @default.
- W2132919130 hasConceptScore W2132919130C2780366003 @default.
- W2132919130 hasConceptScore W2132919130C2780394083 @default.
- W2132919130 hasConceptScore W2132919130C2780817109 @default.
- W2132919130 hasConceptScore W2132919130C502942594 @default.
- W2132919130 hasConceptScore W2132919130C71924100 @default.
- W2132919130 hasIssue "11" @default.
- W2132919130 hasLocation W21329191301 @default.
- W2132919130 hasLocation W21329191302 @default.
- W2132919130 hasOpenAccess W2132919130 @default.
- W2132919130 hasPrimaryLocation W21329191301 @default.
- W2132919130 hasRelatedWork W1607556294 @default.
- W2132919130 hasRelatedWork W1947748380 @default.
- W2132919130 hasRelatedWork W2000280591 @default.
- W2132919130 hasRelatedWork W2008299686 @default.
- W2132919130 hasRelatedWork W2037437441 @default.
- W2132919130 hasRelatedWork W2136651687 @default.
- W2132919130 hasRelatedWork W2142370495 @default.
- W2132919130 hasRelatedWork W2462844398 @default.
- W2132919130 hasRelatedWork W26258096 @default.
- W2132919130 hasRelatedWork W3217566318 @default.
- W2132919130 hasVolume "10" @default.
- W2132919130 isParatext "false" @default.
- W2132919130 isRetracted "false" @default.
- W2132919130 magId "2132919130" @default.
- W2132919130 workType "article" @default.